Sunday, November 11, 2012

• Vertex announced data on on ALS-2200 are being presented at AASLDtheflyonthewall.com (Sun, Nov 11)

Saturday, November 10, 2012

• These Mid-Caps Offer the Best of Both Worldsat Motley Fool (Sat, Nov 10)
• Gilead, Abbott Unwrap Dueling Hep C Pill Dataat TheStreet (Sat, Nov 10)
• Vertex Presents New Phase 3 Data that Showed People with Hepatitis C Treated with Twice-Daily Telaprevir Achieved Viral Cure (SVR12) Rates Similar to Those Treated Three Times DailyBusiness Wire (Sat, Nov 10)
• Data from Viral Kinetic Study Showed Rapid Reduction of HCV RNA with ALS-2200 (VX-135), Vertex’s Oral Nucleotide Analogue in Development for the Treatment of Hepatitis CBusiness Wire (Sat, Nov 10)

Friday, November 9, 2012

• 5 Healthcare Companies With Insider Buying During November 2012 - Part IIIat Seeking Alpha (Fri, Nov 9)

Thursday, November 8, 2012

• For Biotech Investors: 5 Orphan Drugs And Their Parent Companiesat Seeking Alpha (Thu, Nov 8)
• Vertex Announces Webcast of its Presentation at the Credit Suisse 2012 Healthcare ConferenceBusiness Wire (Thu, Nov 8)
• Vertex Pharmaceuticals Stock Hold Recommendation Reiterated (VRTX)at TheStreet (Thu, Nov 8)
• FDA Considering Faster Approval Process for Developers of Drugs for Deadly or Debilitating DiseasesMarketwired (Thu, Nov 8)

Tuesday, November 6, 2012

• VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, Nov 6)

Monday, November 5, 2012

• Disappointing Quarter from VertexZacks (Mon, Nov 5)
• 4-Star Stocks Poised to Pop: Vertex Pharmaceuticalsat Motley Fool (Mon, Nov 5)
• Biotech Weekend Recap: Earnings Reportsat Seeking Alpha (Mon, Nov 5)
• Why I'm Going Long 1 Biotech And Short Another: Earningsat Seeking Alpha (Mon, Nov 5)

Sunday, November 4, 2012

• Why Vertex Pharmaceuticals' Shares Plungedat Motley Fool (Sun, Nov 4)

Friday, November 2, 2012

• Vertex's Shocking Decline Hurts Investorsat Motley Fool (Fri, Nov 2)
• Vertex Reaches Deal With GSK, Mistaken Headline On Questcor: Healthcare Business Recapat Wall St. Cheat Sheet (Fri, Nov 2)
• Can Vertex Overcome Plunging Sales?at Wall St. Cheat Sheet (Fri, Nov 2)
• For Hep C Investors, What Goes Around Comes Aroundat Motley Fool (Fri, Nov 2)
• Stocks Start Firm But End Sloppy As Volume Fadesat Investor's Business Daily (Fri, Nov 2)
• Vertex sinks as Incivek sales decline furtherAP (Fri, Nov 2)
• This Just In: More Upgrades and Downgradesat Motley Fool (Fri, Nov 2)
• Vertex Stock Falls On Unusually High Volume (VRTX)at TheStreet (Fri, Nov 2)
• Vertex shares tank on swing to redat bizjournals.com (Fri, Nov 2)

Add VRTX News to My Yahoo!